Zoetis ZTS
NYSE ZTS
$76.03 -0.65 (-0.85%)
At close: Aug 20, 2026 · 12:58 PM UTC

Zoetis (ZTS) Operating Income Growth (5y) (2017 - 2026)

Zoetis (ZTS) Operating Income Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.08%
Mar 31, 2026 10.35%
Dec 31, 2025 8.86%
Sep 30, 2025 8.37%
Jun 30, 2025 23.59%
Mar 31, 2025 11.31%
Dec 31, 2024 66.06%
Sep 30, 2024 21.90%
Jun 30, 2024 18.92%
Mar 31, 2024 15.95%
Dec 31, 2023 53.74%
Sep 30, 2023 31.98%
Jun 30, 2023 30.75%
Mar 31, 2023 29.45%
Dec 31, 2022 119.14%
Sep 30, 2022 28.87%
Jun 30, 2022 30.27%
Mar 31, 2022 29.77%
Dec 31, 2021 37.49%
Sep 30, 2021 65.45%